0001209191-21-069493.txt : 20211214 0001209191-21-069493.hdr.sgml : 20211214 20211214170023 ACCESSION NUMBER: 0001209191-21-069493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211213 FILED AS OF DATE: 20211214 DATE AS OF CHANGE: 20211214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abel Robert Lorne CENTRAL INDEX KEY: 0001798179 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39206 FILM NUMBER: 211491708 MAIL ADDRESS: STREET 1: SCHRODINGER, INC. STREET 2: 120 WEST 45TH STREET, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Schrodinger, Inc. CENTRAL INDEX KEY: 0001490978 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954284541 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1540 BROADWAY STREET 2: 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 503-299-1150 MAIL ADDRESS: STREET 1: 1540 BROADWAY STREET 2: 24TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-12-13 0 0001490978 Schrodinger, Inc. SDGR 0001798179 Abel Robert Lorne C/O SCHRODINGER, INC., 1540 BROADWAY, 24TH FLOOR NEW YORK NY 10036 0 1 0 0 See Remarks Common Stock 2021-12-13 4 M 0 15601 17.00 A 15601 D Common Stock 2021-12-13 4 S 0 13701 36.1951 D 1900 D Common Stock 2021-12-13 4 S 0 1900 36.8821 D 0 D Stock Option (right to buy) 17.00 2021-12-13 4 M 0 15601 0.00 D 2030-02-05 Common Stock 15601 94756 D These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.77 to $36.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (3) of this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.78 to $36.99, inclusive. This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024. EVP, Chief Computational Scientist, Head of Modeling R&D /s/ Donald Shum, as attorney-in-fact for Robert Lorne Abel 2021-12-14